Stockreport

Amylyx Pharmaceuticals reports results from pancreatic disease treatment trial [Seeking Alpha]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF The trial showed improvement in pancreatic function, as measured by C-peptide response, following 24 weeks of treatment with AMX0035; worsening is typically expected wi [Read more]